Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Hepatology (Baltimore, Md.)|July 29, 2003
Validation and refinement of survival models for liver retransplantationHugo R Rosen, Martin Prieto, Teresa Casanovas-Taltavull, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 2, 2018
Cytomegalovirus reactivation in liver transplant recipients due to hepatitis C cirrhosis is associated with higher cardiovascular risk - an observational, retrospective studyVictoria Aguilera, Tommaso Di Maira, Isabel Conde, et al.
Pharmacogenetics and Genomics|May 21, 2016
Autoantibody presentation in drug-induced liver injury and idiopathic autoimmune hepatitis: the influence of human leucocyte antigen allelesCamilla Stephens, Agustin Castiella, Eva M Gomez-Moreno, et al.
Hepatology (Baltimore, Md.)|January 22, 2011
Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver diseaseYun-Fan Liaw, I-Shyan Sheen, Chuan-Mo Lee, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 9, 2018
Herbal and Dietary Supplement-Induced Liver Injuries in the Spanish DILI RegistryInmaculada Medina-Caliz, Miren Garcia-Cortes, Andres Gonzalez-Jimenez, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 28, 2017
Real-World Effectiveness and Safety of Oral Combination Antiviral Therapy for Hepatitis C Virus Genotype 4 InfectionJavier Crespo, Jose Luis Calleja, Inmaculada Fernández, et al.
Journal of Hepatology|February 4, 2021
Comprehensive analysis and insights gained from long-term experience of the Spanish DILI RegistryCamilla Stephens, Mercedes Robles-Diaz, Inmaculada Medina-Caliz, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 19, 2016
Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infectionRobert J Fontana, Robert S Brown, Ana Moreno-Zamora, et al.
Journal of Hepatology|May 18, 2016
Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injuryInmaculada Medina-Caliz, Mercedes Robles-Diaz, Beatriz Garcia-Muñoz, et al.
Pageof 3